Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

lilly_entrance_web

Eli Lilly to collaborate with diabetes tech companies on insulin pen

May 10, 2021
Sales and Marketing Eli Lilly, diabetes

Eli Lilly has signed strategic international agreements with four companies – Dexcom, Glooko, myDiabby Healthcare, and Roche – with the …

News

Arecor receives £2.8m grant for rapid insulin product

March 31, 2021
Research and Development diabetes, insulin

Arecor has announced today that it has received a £2.8 million grant from Innovate UK, to support the Phase II …

News

ViaCyte and Gore collaborate on new diabetes treatments

March 3, 2021
Research and Development Type 1 diabetes, diabetes, diabetes treatment, gore, viacyte

Clinical stage medicine company ViaCyte have extended their collaboration with materials science organisation Gore to develop new candidates for the …

News
lilly_entrance_web

Eli Lilly’s diabetes drug tirzepatide reduces blood glucose and weight in Phase III trials

February 18, 2021
Eli Lilly, diabetes

Eli Lilly’s tirzepatide led to significant haemoglobin A1C (HbA1C) and body weight reductions from baseline in adults with type 2 …

News
lilly_entrance_web

Lilly’s tirzepatide generates significant reductions in weight and blood sugar in type 2 diabetes patients

December 10, 2020
Research and Development Eli Lilly, diabetes, tirzepatide

Eli Lilly has announced new data for its glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide, showing …

News
pharmafocus_december_2020_cover

The December 2020 issue of Pharmafocus is available to read free online now!

November 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing

The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …

News
download_3

Sun Pharma issues recall of its generic diabetes drug in US market

October 12, 2020
Sales and Marketing FDA, diabetes, recall

Sun Pharma is recalling 747 bottles of its generic diabetes drug Riomet ER in the US.This is due to an …

News
type_2_diabetes_28081593711_1

Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK

September 2, 2020
Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes

Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …

News
gestational_diabetes_kit

Arthritis drug Abatacept could be used to treat type 1 diabetes

August 11, 2020
Manufacturing and Production diabetes, insulin, tye 1, type 2

People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds. Researchers at …

News
indianapolis

Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis

July 24, 2020
Medical Communications Eli Lilly, Humalog, diabetes, insulin

Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …

News
novo

Drug industry suing to overturn Minnesota insulin affordability law

July 2, 2020
Business Services diabetes, insulin, type 1, type 2

The drug industry is suing to overturn a Minnesota law that requires companies to provide emergency insulin to diabetics who …

News
type_2

New data from diabetes prevention programme shows a reduction of type 2 diabetes

June 17, 2020
Research and Development diabetes, type 2 diabetes

The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …

News
fda2outsideweb

Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes

June 12, 2020
Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes

Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …

News
diabetes_3

Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS

May 20, 2020
Research and Development COVID-19, Diabetics, coronavirus, diabetes

People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …

News
diabetes

A quarter of English COVID-19 deaths in hospitals were diabetics

May 15, 2020
Medical Communications COVID-19, coronavirus, diabetes

The NHS’s first data breakdown of underlying health conditions in COVID-19 fatalities has shown that 1 in 4 deaths in …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026